CAK1 inhibitors (GPC)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCAK1 inhibitors (GPC)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCandida Albicans Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGpc Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGpc Biotech
Active IndicationsN/A
Inactive IndicationsCandida Albicans Infections

Other Information

ATC CodeN/A
Related LinksN/A